Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage*; D010958:Plasminogen / Q000096:biosynthesis; D011517:Prothrombin Time; D012171:Retinal Vessels; D013806:Theophylline / Q000008:administration & dosage*; D013923:Thromboembolism / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000188:drug therapy*
D009539:Nicotinic Acids; D005340:Fibrinogen; D010958:Plasminogen; D013806:Theophylline; D005341:Fibrinolysin